biological_process

Cholesterol Efflux

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Cholesterol Efflux: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
5Hypotheses
2Analyses
1Outgoing
3Incoming
0Experiments
6Debates

Summary

The active transport of cholesterol out of cells, primarily mediated by ABCA1 and ABCG1 transporters in macrophages and microglia. Cholesterol efflux to apolipoproteins (APOE, APOA1) is critical for reverse cholesterol transport and lipid homeostasis in the brain. Impaired efflux promotes foam cell formation and contributes to atherosclerosis and neurodegeneration.

Ontology: GO:0033344 · MESH:D002784

No AI portrait yet

🧬 Biological Process Info
Namecholesterol_efflux
Key Genes/ProteinsABCA1, ABCG1
Linked Hypotheses5 hypotheses

Outgoing (1)

TargetRelationTypeStr
lipid_raft_compositionassociated_withcell_type0.50

Incoming (3)

SourceRelationTypeStr
ABCG1regulatesgene0.90
ABCA1activatesgene0.70
ABCA1regulatesgene0.50

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC 0.758 neuroscience APOE4-driven lipid metabolism dysregulat
APOE4 hypolipidation and ABCA1 mistrafficking impair cholest 0.694 molecular-biology Does APOE4's reduced lipid-binding direc
CYP46A1 Activation as a Therapeutic Strategy to Restore Neur 0.550 lipidomics Lipid metabolism dysregulation in Alzhei
ApoE4-Mediated Failure of Cholesterol Efflux as Memory Maint 0.515 neuroinflammation What specific astrocyte-derived factors
ABCA1 Upregulation via LXRβ Agonism to Enhance Cholesterol E 0.380 lipidomics Lipid metabolism dysregulation in Alzhei

Mentioning Analyses (2)

Scientific analyses that reference this entity

Is APOE4's reduced lipid binding pathogenic or a compensatory evolutionary adapt

molecular biology | 2026-04-16 | 9 hypotheses Top: 0.824

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 22 hypotheses Top: 0.852

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
The expanding world of neuroscience. [PMID:39423798] Unknown Cell 2024 0
Neuroscience: Past and Future. [PMID:29621483] Unknown Neuron 2018 0
Neurolaw and Neuroethics. [PMID:30720413] Unknown Camb Q Healthc Ethics 2018 0
Applied neuroscience. [PMID:25247360] Cavanagh Patrick Current biology : CB 2014 0
Neuroscience in recession? [PMID:21505517] Unknown Nat Rev Neurosci 2011 0

Debates (6)

Multi-agent debates referencing this entity

Extended debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Membrane Cholesterol Gradient Modulators

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: Selective Acid Sphingomyelinase Modulation Therapy

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

The skeptic raised evidence that APOE4 carriers show enhanced cholesterol synthe

closed · Rounds: 4 · Score: 0.71 · 2026-04-16

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) c

closed · Rounds: 5 · Score: 0.93 · 2026-04-11

Related Research

Hypotheses and analyses mentioning Cholesterol Efflux in their description or question text

No additional research found